EXTON, Pa., Dec. 22, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2018 dividend of $0.14 per share. The dividend will be paid on February 1, 2018, to shareholders of record as of January 18, 2018.
The Company also announced that management will be presenting an overview of the business at two investor conferences in January and February of 2018. Management will present at the J.P. Morgan Healthcare Conference in San Francisco, California, at 8:30 a.m. PST on Wednesday, January 10, 2018; and at the RBC Capital Markets Global Healthcare Conference in New York, New York, on Wednesday, February 21, 2018.
A live audio webcast of each presentation, as well as the presentation materials, will be accessible from the Company's website at www.westpharma.com/en/investors.
About West
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2016 net sales of $1.5 billion reflect the daily use of approximately 112 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.
Trademarks and registered trademarks are the property of West Pharmaceutical Services, Inc., in the United States and other jurisdictions, unless noted otherwise.
|
Investor Contact: |
Media Contact: |
|
Quintin Lai |
Emily Denney |
|
Vice President, Investor Relations |
Vice President, Global Communications |
|
+1-610-594-3318 |
+1-610-594-3035 |
SOURCE West Pharmaceutical Services, Inc.